Omid C. Farokhzad was the Founder of Selecta Biosciences, which raised more the USD200m.
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
In 2018, he joined Seer as CEO.
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection.
Copyright © Track Record